Latest Therapeutics Stories
Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Gastrointestinal Resections PITTSBURGH, Dec.
Over the past 11 years, thousands of device professionals have attended Medical Device Quality Congress (MDQC) and benefited from the unmatched educational sessions presented by FDA officials
To help manufacturers better understand the final guidance “Circumstances that Constitute Delaying, Denying, Limiting, or Refusing to Permit Drug Inspection,” FDAnews has engaged FDA inspections
This virtual conference is designed to help drug and device manufacturers avoid situations in which manageable compliance issues unexpectedly spiral out of control, turn into a corporate nightmare
REDWOOD CITY, Calif., Dec. 2, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
Poorly designed and executed supplier audits are costing devicemakers millions and run the risk of 483s and warning letters.
The FDA’s focus on drug and devicemakers promotional activities is no longer limited to magazine and TV ads.
Learn the secrets of deciphering 483s and how to use them to pass inspection.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
More Images (2 images) »